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example of this was the finding that
CBTp did not perform significantly bet-
ter than a control treatment of support-
ive counselling, although both did better
than routine care, in the treatment of
delusions. However, supportive counsel-
ling appeared to worsen auditory hallu-
cinations, whilst CBTp resulted in their
reduction (4).
Accepting that CBTp has a beneficial
effect, how then to increase availability?
The apparently simple solution to this is
to train the workforce in these treatment
techniques, thus an increasingly skilled
workforce will increase access and avail-
ability of CBTp. This is based upon a
number of assumptions which may not
be accurate. First, it assumes that training
is available. This is not always true. In the
US there is a lack of training opportuni-
ties (5). In the UK, where training may
be available, it is not clear to what level
of training, experience or skills clinicians
need to be able to deliver CBTp.
With the heterogeneity and variation
in CBTp, it is not clear what should
be taught. What are the necessary tech-
niques and competencies, assuming it
is possible to try and define these, a
difficult task at the best. Given that
psychotic disorders are notoriously dif-
ficult to treat, it might be expected
that the most qualified and experienced
practitioners would provide treatment,
as would be the case, say, with complex
heart surgery. But this is rarely the case
in mental health services, where costs
are the main driver. Thus, there is fre-
quently a move to employ the cheapest
staff and provide the minimum training
necessary when rolling out new treat-
ments, which could dilute treatment
effects and be poor value for money.
Once trained staff return to their
work place, they do not necessarily
receive the management support and
have the time to implement their train-
ing. Furthermore, having received train-
ing, staff may no longer be willing to
work on the front line and, having be-
come more qualified, they may prefer to
take up teaching or research posts.
Thus, training has the unanticipated
effect of depleting the skilled work-
force rather than enhancing it.
Lastly, what of the future? I would
like to raise a few possibilities. First,
an integration with neuroscience, so
that investigations on brain plasticity
effects of cognitive, behavioral and
social interventions can be undertak-
en. Second, a greater focus on positive
emotions and clinical methods which
elicit and encourage these as part of a
treatment strategy, from both a theo-
retical and clinical perspective. For
example, broaden-and-build theories
(6) and broad minded affective coping
intervention (7,8). Third, the potential
for the use of new technologies as a
delivery platform for psychological
interventions (9). This would include
the use of mobile phone technology for
real time assessment and interventions
and the use of intelligent systems to
individualize interventions and identi-
fy critical time points (10). The possi-
bilities here for the widespread appli-
cation of CBT in the developing world,
where mobile phones are ubiquitous
but health system infrastructure is
undeveloped and prohibitively expen-
sive, by “leap frogging” the normal
pedestrian development (or lack of it)
of mental health care, are exciting.
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Cognitive behavior therapy (CBT)
for severe mental illness has acquired
a solid scientific status. Although the
effect sizes are small to moderate, they
are also quite robust and re-established
in many meta-analyses over the last
decade. Small to moderate effect sizes
are common in adjunctive therapies,
since the adjunctive intervention has
to add further effects to a treatment
which is already efficacious.
The conclusion at this moment is
that monotherapy with pharmacologi-
cal agents such as antipsychotic medi-
cation and antidepressants does not
constitute optimal treatment for severe
257
mental illness. CBT can add to that with
improved symptom reduction and few-
er relapses in cases of depression (1). In
children and adolescents, early inter-
vention services for psychosis, deliver-
ing CBT and other interventions, are
cost-effective (2). CBT has been found
to be effective in the prevention of a first
episode of psychosis in meta-analyses
(3), and also cost-effective (4,5). So,
CBT adds health gains for lower costs.
Why not implement CBT in routine
services?
Here we meet the biggest challenge
for CBT in severe mental illness. Al-
though CBT for schizophrenia has been
recommended in several guidelines (e.g.,
6) for over a decade, the accessibility in
routine services even in England, where
CBT for psychosis is most promoted and
researched, is dramatically low (7).
The pharmaceutical industry has
built an implementation infrastructure
that is missing in psychosocial and psy-
chological interventions. Whenever a
new drug is released on the market, a
substantial marketing budget is used on
merchandising. Hundreds of salesmen
will then visit doctors with brochures,
free specimens and small gifts. In this
way, the medication is successfully dis-
seminated in the routine practices of the
prescribers in a relatively short time.
The challenge for CBT is that the profes-
sionals who will deliver the intervention
first have to be trained and employed by
the services, while a marketing budget is
completely lacking. Training takes sev-
eral years, and vacancies are not auto-
matically open after training. This slows
down the process enormously.
The caseload for a CBT therapist
is much lower than for a medication-
prescribing psychiatrist. Many more
CBT therapists are needed to guarantee
an access to CBT comparable to the
access to drug treatment. Several thera-
pists have been training nurses in CBT,
but these nurses in general have too lit-
tle knowledge of general psychopathol-
ogy to develop adequate individually
tailored case formulations, and perma-
nent supervision is often needed.
Training of nurses and low-intensity
therapists in CBT interventions directed
at accomplishing a patient’s personal
goal has been successful. These inter-
ventions are more broadly accessible to
service users, but the need for more spe-
cialized CBT for complex cases is not
diminished (8). At some places in the
Netherlands, CBT therapists work in
teams with nurses, where the CBT
therapist develops the individually tai-
lored case formulation and the nurse
is conducting parts of the therapy such
as exposure exercises, self-esteem pro-
tocols, relaxation exercises. In this way,
the shortage of CBT therapists working
with patients with severe mental illness
can partly be overcome.
On the other hand, CBT is a trans-
diagnostic intervention, successfully
applied to almost all psychiatric condi-
tions. The underlying mechanisms of
(for instance) selective attention and
avoidance behavior are common to
several anxiety disorders, depression,
eating disorders and also paranoid
delusions. This is certainly an advan-
tage. A therapist can use the principles
of CBT in several kinds of disorders,
and comorbid disorders as well. Train-
ing can be limited to the universal prin-
ciples, and only small adjustments are
needed for each disorder, such as dif-
ferent assessment instruments, a differ-
ent speed of progress through the pro-
tocol, and different attitudes in case
formulation dependent on the patient’s
illness insight. Because of the universal
nature of generic CBT, therapists
working in other psychiatric domains
could easily enter the field of severe
mental illness with little extra training.
This advantage of universality is,
however, a disadvantage as well. Ge-
neric therapy might not be targeted
enough for the specific problems of
some patients. In recent years, more
specific variants of CBT have been de-
veloped and successfully tested for
psychotic symptoms, command hallu-
cinations, and negative symptoms. Dis-
semination is not the dissemination of
a final intervention. The intervention is
at the same time improved and differ-
entiated to address more specific prob-
lems with improved efficacy.
In conclusion, we can state that CBT
has reached such a level of adjunctive
effectiveness in severe mental illness
that pharmacological monotherapy is
not the optimal treatment anymore.
CBT must be made available and ac-
cessible in routine psychiatric practice.
This can only be accomplished if budg-
ets are reallocated from clinical serv-
ices with high 24-hour staffing needs to
less labour-intensive outpatient services
with more specialized interventions
directed at symptomatic and social
remission. The era of implementation
has a slow start, but there is progress.
At the same time, there is room for
improvement of CBT protocols by more
specific and symptom-tailored interven-
tions. The era of research has just begun
for psychological treatments such as
CBT in severe mental illness.
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